The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians-Reference-Cited by-同舟云学术

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

Published:2018-05-25 Issue:40 Volume:9 Page:26217-26225
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kähler Katharina C.¹,Blome Christine²,Forschner Andrea³,Gutzmer Ralf⁴,Hauschild Axel¹,Heinzerling Lucie⁵,Livingstone Elisabeth⁶,Loquai Carmen⁷,Müller-Brenne Tina⁷,Schadendorf Dirk⁶,Utikal Jochen⁸,Wagner Tobias²,Augustin Matthias²

Affiliation:

1. Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany

2. Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg, Hamburg, Germany

3. Department of Dermatology, Eberhard-Karls University of Tübingen, Tübingen, Germany

4. Department of Dermatology, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany

5. Department of Dermatology, University Hospital Erlangen, Erlangen, Germany

6. Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany

7. Department of Dermatology, University of Mainz, Mainz, Germany

8. Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Mannheim, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk willingness in multiple system atrophy and Parkinson’s disease understanding patient preferences;npj Parkinson's Disease;2024-08-15

2. Patient Voices in Rheumatic Immune-related Adverse Events;Rheumatic Disease Clinics of North America;2024-05

3. Differences between physician and patient preferences for cancer treatments: a systematic review;BMC Cancer;2023-11-18

4. Patientenpräferenzen für die Therapie fortgeschrittener Melanome: Einfluss von Komorbidität;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-01

5. Patient preferences for treatment of advanced melanoma: impact of comorbidities;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2020-10-04